Eczema herpeticatum;Eczema herpeticatum

Hautarzt

Volumn 55, Issue 7, 2004, Pages 646-652

  Wetzel, S ^a   Wollenberg, A ^a  

^a UNIVERSITY OF MUNICH   (Germany)

Author keywords

Acyclovir; Atopic dermatitis; Eczema herpeticum; Herpes simplex virus

Indexed keywords

ACICLOVIR; ANTIVIRUS AGENT; CIDOFOVIR; IMIQUIMOD; IMMUNOGLOBULIN;

ATOPIC DERMATITIS; BLISTER; CLINICAL FEATURE; CRYOTHERAPY; DIAGNOSTIC PROCEDURE; DIFFERENTIAL DIAGNOSIS; DISEASE COURSE; DISEASE PREDISPOSITION; ELECTRON MICROSCOPY; ELECTROSURGERY; EPIDEMIOLOGICAL DATA; HERPES SIMPLEX; HERPES SIMPLEX VIRUS; HUMAN; IMMUNOFLUORESCENCE; POLYMERASE CHAIN REACTION; PUSTULE; REVIEW; SEROLOGY; SKIN DEFECT; TREATMENT OUTCOME; TZANCK TEST; VIRUS CULTURE; VIRUS PATHOGENESIS;

EID: 3242662482     PISSN: 00178470     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00105-004-0744-1     Document Type: Review

References (76)

1. Bartralot R, Garcia-Patos V, Rodriguez-Cano L, Castells A (1996) Kaposi's varicelliform eruption in a patient with healing second degree burns. Clin Exp Dermatol 21:127-130
2. Bernstein DI (2001) Potential for immunotherapy in the treatment of herpesvirus infections. Herpes 8:8-11
3. Blackford S, Roberts DL, Thomas PD (1993) Cowpox infection causing a generalized eruption in a patient with atopic dermatitis. Br J Dermatol 129:628-629
4. Bork K, Bräuninger W (1988) Increasing incidence of eczema herpeticum: analysis of seventy-five cases. J Am Acad Dermatol 19:1024-1029
5. Bornhövd E, Wollenberg A (2003) Topische Immunmodulatoren zur Ekzembehandlung. Allergo J 12:456-462
6. Braun-Falco O, Plewig G, Wolf HH, Burgdorf WHC (2002) Dermatology. Springer, Berlin Heidelberg New York Tokyo
7. Breuer K, S HA, Kapp A, Werfel T (2002) Staphylococcus aureus: colonizing features and influence of an antibacterial treatment in adults with atopic dermatitis. Br J Dermatol 147:55-61
8. Brion N, Guillaume JC, Dubertret L, Touraine R (1981) Herpes cutane dissemine de l'adulte et syndrome de Sezary. Ann Dermatol Venereol 108:517-521
9. Bundesverband der Pharmazeutischen Industrie (2003) Arzneimittelverzeichnis. Editio Cantor, Aulendorf
10. Burke RL, Goldbeck C, Ng P et al. (1994) The influence of adjuvant on the therapeutic efficacy of a recombinant genital herpes vaccine. J Infect Dis 170:1110-1119
11. Cesario T, Fife LT, Rayhan S, Emmons R (1977) Cutaneous dissemination of herpes simplex virus in individuals fifteen years of age and older. Am J Med Sci 273:345-353
12. Collins P (1993) Mechanisms of herpes virus resistance. Ann Med 25:441-445
13. Engler RJM, Kenner J, Leung DY (2002) Smallpox vaccination: risk considerations for patients with atopic dermatitis. J Allergy Clin Immunol 110:357-365
14. Feldman F, Newman B (1955) Eczema herpeticum (Kaposi's varicelliform eruption). Arch Dermatol 71:399-401
15. Fivenson DP, Breneman DL (1989) A rapidly progressive papulovesicular eruption. Eczema herpeticum/Kaposi's varicelliform eruption. Arch Dermatol 125:1570,1572-1573
16. Fivenson DP, Breneman DL, Wander AH (1990) Kaposi's varicelliform eruption. Absence of ocular involvement. Arch Dermatol 126:1037-1039
17. Frühwald R (1934) Pustulosis vacciniformis acuta. Dermatol Wochenschr 28:922-937
18. Gallo RL, Murakami M, Ohtake T, Zaiou M (2002) Biology and clinical relevance of naturally occurring antimicrobial peptides. J Allergy Clin Immunol 110:823-831
19. Ganz T (1999) Defensins and host defense. Science 286:420-421
20. Harrison CJ, Miller RL, Bernstein DI (2001) Reduction of recurrent HSV disease using imiquimod alone or combined with a glycoprotein vaccine. Vaccine 19:1820-1826
21. Higgins CR, Schofield JK, Tatnall FM, Leigh IM (1993) Natural history, management and complications of herpes labialis. J Med Virol Suppl 1:22-26
22. Higgins PG, Crow KD (1973) Recurrent Kaposi's varicelli-form eruption in Darier's disease. Br J Dermatol 88:391-394
23. Jacobs R (1998) Neonatal herpes simplex virus infection. Semin Perinatol 22:64-71
24. Juliusberg F (1898) Über Pustulosis acuta varioliformis. Arch Dermatol Syph 46:22-28
25. Kaposi M (1887) Pathologie und Therapie der Hautkrankheiten. Urban und Schwarzenberg, Wien
26. Kapp A, Papp K, Bingham A et al. (2002) Long-term management of atopic dermatitis in infants with topical pimecrolimus, a nonsteroid anti-inflammatory drug. J Allergy Clin Immunol 110:277-284
27. Kerschenlohr K, Schaller UC, Messmer EM, Wollenberg A (2003) Das Lidekzem. Eine therapeutische Herausforderung. Ophthalmologe 100:240-251
28. Kessler HA, Hurwitz S, Farthing C et al. (1996) Pilot study of topical trifluridine for the treatment of acyclovir-resistant mucocutaneous herpes simplex disease in patients with AID5 (ACTG 172). AID5 Clinical Trials Group. J Acquir Immune Defic Syndr Hum Retrovirol 12:147-152
29. Korting HC, Abeck D, Schmoeckel C (1987) Vergleichende Bewertung des Herpes-Virus-Nachweises mittels fluoreszenzmarkierter monoklonaler Antikorper und elektronenmikroskopischer Negativkontrasttechnik bei dermato-venerologischen Erkrankungen. Ergebnisse einer Pilotstudie an 30 Patienten. Hautarzt 38:723-726
30. Krieg H (1950) Eccema herpeticum - Eine Herpes-simplex-Infektion (Pustulosis varioliformis acuta, Kaposi-Juliusberg). Dermatol Wochenschr 121:461-469
31. Kriegk H (1952) Eccema herpeticum. Dermatol Wochenschr 125:230-231
32. Krug A, Rothenfusser S, Hornung V et al. (2001) Identification of CpG oligonucleoticle sequences with high induction of IFN-a/-b in plasmacytoid dendritic cells. Eur J Immunol 31:2154-2163
33. Lausecker H (1953) Kaposis varizelliforme Eruption - Eczema herpetiforme. Arch Derm Syph 196:183-222
34. Lübbe J (2003) Klinische Erfahrungen mit topischen Calcineurininhibitoren in der Praxis. Hautarzt 54:432-439
35. Lübbe J, Pournaras CC, Saurat JH (2000) Eczema herpeticum during treatment of atopic dermatitis with 0.1% tacrolimus ointment. Dermatology 201:249-251
36. Marshall DS, Linfert DR, Draghi A et al. (2001) Identification of herpes simplex virus genital infection: comparison of a multiplex PCR assay and traditional viral isolation techniques. Mod Pathol 14:152-156
37. Martins-Castro R, Proenca N, de Salles-Gomes LF (1974) On the association of some dermatoses with South American pemphigus foliaceus. Int J Dermatol 13:271-275
38. Masessa JM, Grossman ME, Knobler EH, Bank DE (1989) Kaposi's varicelliform eruption in cutaneous T cell lymphoma. J Am Acad Dermatol 21:133-135
39. Maudgal PC, Missotten L, De Clercq E et al. (1981) Efficacy of (E)-5-(2-bromovinyl)-2′-deoxyuridine in the topical treatment of herpes simplex keratitis. Albrecht Von Graefes Arch Klin Exp Ophthalmol 216:261-268
40. Moses A, Cohen-Poradosu R (2002) Eczema vaccinatum - A timely reminder. N Engl J Med 346:1287
41. Nasemann T (1961) Das Eczema herpeticatum (Eczema herpetiforme Kaposi). In: Jadassohn J (Hrsg) Handbuch der Haut- und Geschlechtskrankheiten. Springer, Berlin S315-331
42. Nishimura M, Maekawa M, Hino Y et al. (1984) Kaposi's varicelliform eruption. Development in a patient with a healing second-degree burn. Arch Dermatol 120:799-800
43. Novelli VM, Atherton DJ, Marshall WC (1988) Eczema herpeticum. Clinical and laboratory features. Clin Pediatr (Phila) 27:231-233
44. Ogawa H (1986) Atopic aspect of eosinophilic nasal polyposis and a possible mechanism of eosinophil accumulation. Acta Otolaryngol 430:12-17
45. Ong PY, OhtakeT, Brandt C et al. (2002) Endogenous antimicrobial peptides and skin infections in atopic dermatitis. N Engl J Med 347:1151-1160
46. Ophir J, Brenner S, Bali R et al. (1995) Effect of topical interferon-beta on recurrence rates in genital herpes: a double-blind, placebo-controlled, randomized study. J Interferon Cytokine Res 15:625-631
47. Panda A, Das GK, Khokhar S et al. (1995) Efficacy of four antiviral agents in the treatment of uncomplicated herpetic keratitis. Can J Ophthalmol 30:256-258
48. Rappersberger K (1999) Infektionen mit Herpes-simplex und Varizella-Zoster-Viren in der Schwangerschaft. Klinische Manifestationen bei Mutter, Fötus und Neugeborenen - therapeutische Optionen. Hautarzt 50:706-714
49. Reitamo S, Rustin M, Ruzicka T et al. (2002) Efficacy and safety of tacrolimus ointment compared with that of hydrocortisone butyrate ointment in adult patients with atopic dermatitis. J Allergy Clin Immunol 109:547-555
50. Reitamo S, Wollenberg A, Schöpf E et al. (2000) Safety and efficacy of 1 year of tacrolimus ointment monotherapy in adults with atopic dermatitis. Arch Dermatol 136:999-1006
51. Rozenberg F (2002) Signification et limites des moyens diagnostiques fondes sur la PCR dans l'herpes oro-facial, genital, de la femme enceinte, du nouveau-ne a risque. Ann Dermatol Venereol 129:617-624
52. Ruchman I, Welsh A, Dodd K (1947) Kaposi's varicelliform eruption. Arch Dermatol 56:846-863
53. Sanderson IR, Brueton LA, Savage MO, Harper JI (1987) Eczema herpeticum: a potentially fatal disease. Br Med J (Clin Res Ed) 294:693-694
54. Schacker TW, Conant M, Thoming C et al. (2002) Imiquimod 5-percent cream does not alter the natural history of recurrent herpes genitalis: a phase II, randomized, double-blind, placebo-controlled study. Antimicrob Agents Chemother 46:3243-3248
55. Schirren H, Schirren C, Schlüpen E et al. (1995) Exazerbation eines Morbus Hailey-Hailey durch Infektion mit Herpes-simplex-Virus. Nachweis mittels Polymerasekettenreaktion. Hautarzt 46:494-497
56. Seidenberg S (1941) Zur Ätiologie der Pustulosis vacciniformis acuta. Schweiz Z Path U Bakt 4:398-401
57. Spruance SL, Nett R, Marbury T et al. (2002) Acyclovir cream for treatment of herpes simplex labialis: results of two randomized, double-blind, vehicle-controlled, multicenter clinical trials. Antimicrob Agents Chemother 46:2238-2243
58. Spruance SL, Tyring SK, Smith MH, Meng TC (2001) Application of a topical immune response modifier, resiquimod gel, to modify the recurrence rate of recurrent genital herpes: a pilot study. J Infect Dis 184:196-200
59. Stanberry LR, Spruance SL, Cunningham AL et al. (2002) Glycoprotein-D-adjuvant vaccine to prevent genital herpes. N EngI J Med 347:1652-1661
60. Straus SE, Corey L, Burke RL et al. (1994) Placebo-controlled trial of vaccination with recombinant glycoprotein D of herpes simplex virus type 2 for immunotherapy of genital herpes. Lancet 343:1460-1463
61. Tabery HM (2001) Healing of recurrent herpes simplex corneal epithelial lesions treated with topical acyclovir A non-contact photomicrographic in vivo study in the human cornea. Acta Ophthalmol Scand 79:256-261
62. Verbov J, Munro DD, Miller A (1972) Recurrent eczema herpeticum associated with ichthyosis vulgaris. Br J Dermatol 86:638-640
63. Virella-Lowell I, Poirier A, Chesnut KA et al. (2000) Inhibition of recombinant adeno-associated virus (rAAV) transduction by bronchial secretions from cystic fibrosis patients. Gene Ther 7:1783-1789
64. Wahn U, Bos JD, Goodfield M et al. (2002) Efficacy and safety of pimecrolimus cream in the long-term management of atopic dermatitis in children. Pediatrics 110:e2
65. Wheeler CE Jr, Abele DC (1966) Eczema herpeticum, primary and recurrent. Arch Dermatol 93:162-173
66. Wienecke R, Wolff H, Schaller M et al. (2000) Cowpock virus infection in an 11-year-old-girl. J Am Acad Dermatol 42:892-894
67. Wilhelmus KR (2003) Interventions for herpes simplex virus epithelial keratitis. Cochrane Database Syst Rev CD002898
68. Wollenberg A, Baldauf C, Ruëff F, Przybilla B (2000) Allergische Kontaktdermatitis und Arzneiexanthem auf Aciclovir - Kreuzreaktion auf Ganciclovir. Allergo J 9:96-99
69. Wollenberg A, Bieber T (2000) Atopic dermatitis: from the genes to skin lesions. Allergy 55:205-213
70. Wollenberg A, Degitz K (1995) Eczema herpeticatum in graviditate. Dtsch Med Wochenschr 120:1395-1398
71. Wollenberg A, Melnik B, Buslau M, Hein R (2001) Essentielle diagnostische Verfahren in der Dermatologie. In: Plewig G, Degitz K (Hrsg) Fortschritte der praktischen Dermatologie und Venerologie. Springer, Berlin Heidelberg New York Tokyo, S 499-505
72. Wollenberg A, Wagner M, Günther S et al. (2002) Plasmacytoid dendritic cells: a new cutaneous dendritic cell subset with distinct role in inflammatory skin diseases. J Invest Dermatol 119:1096-1102
73. Wollenberg A, Wetzel S, Burgdorf WHC, Haas J (2003) Viral infections in atopic dermatitis - pathogenic aspects and clinical management. J Allergy Clin Immunol 112:667-674
74. Wollenberg A, Zoch C, Wetzel S et al. (2003) Predisposing factors and clinical features of eczema herpeticum - a retrospective analysis of 100 cases. J Am Acad Dermatol 49:198-205
75. Wutzler P, Sauerbrei A, Sprossig M et al. (1985) Klinische und virologische Untersuchungen zum Eczema herpeticatum. Dermatol Monatsschr 171:222-229
76. Yao Y, Inoue Y, Kase T et al. (1996) Clinical characteristics of acyclovir-resistant herpetic keratitis and experimental studies of isolates. Graefes Arch Clin Exp Ophthalmol 234[Suppl 1]:126-132